OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

Saved in:
Bibliographic Details
Title: OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.
Authors: Schultheiß C; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland., Besemer B; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland., Willscher E; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Paschold L; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Mersceman T; Enterome SA, Paris, France., Talpin A; Enterome SA, Paris, France., Serger C; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Cancer Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland., Zippelius A; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Laboratory of Cancer Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland., Berruti A; Università degli Studi di Brescia, Azienda Ospedaliera Spedali Civili, Brescia, Italy., Grisanti S; Università degli Studi di Brescia, Azienda Ospedaliera Spedali Civili, Brescia, Italy., Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam UMC, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Baudin E; Endocrine Oncology, Gustave Roussy, Villejuif, France., Landwehr LS; Internal Medicine, University Hospital Würzburg, Würzburg, Germany., Capdevila J; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Subbiah V; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Granberg D; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Karolinska University Hospital Solna, Stockholm, Sweden., Gedske Daugaard K; Medical Oncology, Rigshospitalet/University Hospital, Copenhagen, Denmark., Triebig A; Medicine IV Endocrine Oncology, Ludwig Maximilians University of Munich, München, Germany., Gauduchon T; Medical Oncology, Centre Léon Bérard, Lyon, France., Do Cao C; University Hospital Lille - Hôpital Claude Huriez, Lille, France., Garcia ME; Hospital Nord, Marseille, France., Magalhaes J; Enterome SA, Paris, France., Chêne L; Enterome SA, Paris, France., Binder M; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland. Mascha.Binder@unibas.ch.; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland. Mascha.Binder@unibas.ch.; Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany. Mascha.Binder@unibas.ch.
Source: Communications medicine [Commun Med (Lond)] 2026 Jul 06. Date of Electronic Publication: 2026 Jul 06.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond)
Database: MEDLINE Ultimate
Description
ISSN:2730-664X
DOI:10.1038/s43856-026-01755-8